EoCene Ltd. (EOCN) stock
EOCNNasdaqPharmaceutical PreparationsFiscal year ends December 31
$2.20−0.26 (-10.63%)
Close on Nov 18, 2026Market cap $2.20MP/E –Yield –
EoCene net income
Net income is the profit left for shareholders after every expense, interest and tax.
EoCene's net income for the twelve months ending Jun 30, 2026 was -$11.34M. For fiscal 2025 it was -$10.31M. The highest annual figure on record is -$6.91M in fiscal 2023.
Annual net income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$10.31M | – |
| FY2024 | Dec 31, 2024 | -$7.52M | – |
| FY2023 | Dec 31, 2023 | -$6.91M | – |
| FY2022 | Dec 31, 2022 | -$17.87M | – |
| FY2021 | Dec 31, 2021 | -$32.47M | – |
| FY2020 | Dec 31, 2020 | -$28.77M | – |
| FY2019 | Dec 31, 2019 | -$20.46M | – |
Quarterly net income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$2.72M | – |
| Q1 FY2026 | Mar 31, 2026 | -$1.91M | – |
| Q4 FY2025 | Dec 31, 2025 | -$4.82M | – |
| Q3 FY2025 | Sep 30, 2025 | -$1.89M | – |
| Q2 FY2025 | Jun 30, 2025 | -$2.50M | – |
| Q1 FY2025 | Mar 31, 2025 | -$1.10M | – |
| Q4 FY2024 | Dec 31, 2024 | -$3.21M | – |
| Q3 FY2024 | Sep 30, 2024 | -$1.91M | – |
| Q2 FY2024 | Jun 30, 2024 | -$1.12M | – |
| Q1 FY2024 | Mar 31, 2024 | -$1.28M | – |
| Q2 FY2023 | Jun 30, 2023 | -$1.59M | – |
| Q1 FY2023 | Mar 31, 2023 | -$1.83M | – |
| Q2 FY2022 | Jun 30, 2022 | -$3.73M | – |
| Q1 FY2022 | Mar 31, 2022 | -$6.14M | – |
| Q2 FY2021 | Jun 30, 2021 | -$8.40M | – |
| Q1 FY2021 | Mar 31, 2021 | -$8.91M | – |
| Q2 FY2020 | Jun 30, 2020 | -$5.53M | – |
| Q1 FY2020 | Mar 31, 2020 | -$6.06M | – |
See a number that looks wrong?